Allmed Medical Products Co Ltd Class A (002950) — Capital Reinvestment Ratio
Allmed Medical Products Co Ltd Class A (002950) has a Capital Reinvestment Ratio of 0.37x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥206.33 Million) in capital expenditures (CN¥75.70 Million). Check how tangible is Allmed Medical Products Co Ltd Class A's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Allmed Medical Products Co Ltd Class A Capital Reinvestment Ratio (2014–2025)
This chart tracks Allmed Medical Products Co Ltd Class A's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see Allmed Medical Products Co Ltd Class A (002950) cash conversion ratio.
Annual Capital Reinvestment Ratio for Allmed Medical Products Co Ltd Class A (2014–2025)
Year-by-year Capital Reinvestment Ratio for Allmed Medical Products Co Ltd Class A from 2014 to 2025. See 002950 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | CN¥717.13 Million | CN¥260.32 Million | ▲ +64.5% |
| 2024 | 0.22x | CN¥711.64 Million | CN¥157.00 Million | ▼ -67.4% |
| 2023 | 0.68x | CN¥423.50 Million | CN¥286.48 Million | ▲ +95.4% |
| 2022 | 0.35x | CN¥1.15 Billion | CN¥398.05 Million | ▼ -55.4% |
| 2021 | 0.78x | CN¥374.85 Million | CN¥290.70 Million | ▲ +358.0% |
| 2020 | 0.17x | CN¥1.44 Billion | CN¥243.28 Million | ▼ -80.1% |
| 2019 | 0.85x | CN¥273.13 Million | CN¥232.55 Million | ▼ -99.1% |
| 2018 | 95.41x | CN¥3.01 Million | CN¥287.07 Million | ▲ +4540.8% |
| 2017 | 2.06x | CN¥197.25 Million | CN¥405.55 Million | ▲ +505.7% |
| 2016 | 0.34x | CN¥472.74 Million | CN¥160.47 Million | ▼ -26.1% |
| 2015 | 0.46x | CN¥217.68 Million | CN¥99.92 Million | ▲ +43.0% |
| 2014 | 0.32x | CN¥293.45 Million | CN¥94.19 Million | — |